Classification for long-term survival in oligometastatic patients treated with ablative radiotherapy: A multi-institutional pooled analysis.
Julian C HongDiandra N Ayala-PeacockJason LeeA William BlackstockPaul OkunieffMax W SungRalph R WeichselbaumJohnny KaoJames J UrbanicMichael T MilanoSteven J ChmuraJoseph K SalamaPublished in: PloS one (2018)
We identified clinical factors defining oligometastatic patients with favorable outcomes, who we hypothesize are most likely to benefit from metastasis-directed therapy.